Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Research ArticleTheranostics
Open Access

Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy

Frederik L. Giesel, Karina Knorr, Fabian Spohn, Leon Will, Tobias Maurer, Paul Flechsig, Oliver Neels, Kilian Schiller, Horacio Amaral, Wolfgang A. Weber, Uwe Haberkorn, Markus Schwaiger, Clemens Kratochwil, Peter Choyke, Vasko Kramer, Klaus Kopka and Matthias Eiber
Journal of Nuclear Medicine March 2019, 60 (3) 362-368; DOI: https://doi.org/10.2967/jnumed.118.212233
Frederik L. Giesel
1Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany
2German Cancer Consortium (DKTK), Heidelberg, Germany
3CCU Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karina Knorr
4Department of Nuclear Medicine, Technical University Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabian Spohn
1Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany
2German Cancer Consortium (DKTK), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leon Will
1Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tobias Maurer
5Department of Urology, Technical University Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Flechsig
1Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliver Neels
2German Cancer Consortium (DKTK), Heidelberg, Germany
6Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kilian Schiller
7Department of Radiation Oncology, Technical University Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Horacio Amaral
8Center of Nuclear Medicine, PositronMed, FALP, Santiago, Chile; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang A. Weber
4Department of Nuclear Medicine, Technical University Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Uwe Haberkorn
1Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany
3CCU Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Schwaiger
4Department of Nuclear Medicine, Technical University Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clemens Kratochwil
1Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Choyke
9Molecular Imaging Program, National Cancer Institute, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vasko Kramer
8Center of Nuclear Medicine, PositronMed, FALP, Santiago, Chile; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Klaus Kopka
2German Cancer Consortium (DKTK), Heidelberg, Germany
6Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Eiber
2German Cancer Consortium (DKTK), Heidelberg, Germany
4Department of Nuclear Medicine, Technical University Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 60 no. 3 362-368
DOI 
https://doi.org/10.2967/jnumed.118.212233
PubMed 
30042163

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication April 2, 2018
  • Accepted for publication June 23, 2018
  • Published online March 1, 2019.

Article Versions

  • previous version (July 24, 2018 - 10:34).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2019 by the Society of Nuclear Medicine and Molecular Imaging. Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: http://jnm.snmjournals.org/site/misc/permission.xhtml.

Author Information

  1. Frederik L. Giesel1–3,
  2. Karina Knorr4,
  3. Fabian Spohn1,2,
  4. Leon Will1,
  5. Tobias Maurer5,
  6. Paul Flechsig1,
  7. Oliver Neels2,6,
  8. Kilian Schiller7,
  9. Horacio Amaral8,
  10. Wolfgang A. Weber4,
  11. Uwe Haberkorn1,3,
  12. Markus Schwaiger4,
  13. Clemens Kratochwil1,
  14. Peter Choyke9,
  15. Vasko Kramer8,
  16. Klaus Kopka2,6 and
  17. Matthias Eiber2,4
  1. 1Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany
  2. 2German Cancer Consortium (DKTK), Heidelberg, Germany
  3. 3CCU Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany
  4. 4Department of Nuclear Medicine, Technical University Munich, Munich, Germany
  5. 5Department of Urology, Technical University Munich, Munich, Germany
  6. 6Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Heidelberg, Germany
  7. 7Department of Radiation Oncology, Technical University Munich, Munich, Germany
  8. 8Center of Nuclear Medicine, PositronMed, FALP, Santiago, Chile; and
  9. 9Molecular Imaging Program, National Cancer Institute, Bethesda, Maryland
  1. For correspondence or reprints contact: Frederik L. Giesel, Department of Nuclear Medicine, Heidelberg University Hospital INF 400, 69120 Heidelberg, Germany. E-mail: frederik{at}egiesel.com
View Full Text

Statistics from Altmetric.com

Cited By...

  • 146 Citations
  • Google Scholar

Article usage

Article usage: July 2018 to April 2022

AbstractFullPdf
Jul 20185360143
Aug 20184910246
Sep 20182600206
Oct 20182280186
Nov 20181660156
Dec 20181810135
Jan 20191260147
Feb 20191110150
Mar 20191396134480
Apr 201942756185
May 201924551155
Jun 201915533121
Jul 201915339136
Aug 20191033781
Sep 20197747116
Oct 201913763131
Nov 201911832115
Dec 2019952190
Jan 20201181890
Feb 2020913295
Mar 20201056778
Apr 20201107895
May 202011507889
Jun 2020125447104
Jul 20204913478
Aug 202023359130
Sep 20206335490
Oct 20202607386
Nov 20201867779
Dec 20201135266
Jan 202171214104
Feb 202172268121
Mar 20216190100
Apr 2021467485
May 202154107112
Jun 2021497673
Jul 2021306874
Aug 2021436879
Sep 2021478976
Oct 2021346176
Nov 20215177108
Dec 2021368475
Jan 2022467672
Feb 20224012566
Mar 202250251101
Apr 2022339985
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 60 (3)
Journal of Nuclear Medicine
Vol. 60, Issue 3
March 1, 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
Frederik L. Giesel, Karina Knorr, Fabian Spohn, Leon Will, Tobias Maurer, Paul Flechsig, Oliver Neels, Kilian Schiller, Horacio Amaral, Wolfgang A. Weber, Uwe Haberkorn, Markus Schwaiger, Clemens Kratochwil, Peter Choyke, Vasko Kramer, Klaus Kopka, Matthias Eiber
Journal of Nuclear Medicine Mar 2019, 60 (3) 362-368; DOI: 10.2967/jnumed.118.212233

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
Frederik L. Giesel, Karina Knorr, Fabian Spohn, Leon Will, Tobias Maurer, Paul Flechsig, Oliver Neels, Kilian Schiller, Horacio Amaral, Wolfgang A. Weber, Uwe Haberkorn, Markus Schwaiger, Clemens Kratochwil, Peter Choyke, Vasko Kramer, Klaus Kopka, Matthias Eiber
Journal of Nuclear Medicine Mar 2019, 60 (3) 362-368; DOI: 10.2967/jnumed.118.212233
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Theranostics

  • A novel dimeric FAP-targeting small molecule-radio conjugate with high and prolonged tumour uptake
  • 89Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted 227Th-conjugate therapy in mice
  • A pipeline for automated voxel dosimetry: application in patients with multi-SPECT/CT imaging following 177Lu peptide receptor radionuclide therapy
Show more Theranostics

Clinical

  • A novel dimeric FAP-targeting small molecule-radio conjugate with high and prolonged tumour uptake
  • 89Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted 227Th-conjugate therapy in mice
  • A pipeline for automated voxel dosimetry: application in patients with multi-SPECT/CT imaging following 177Lu peptide receptor radionuclide therapy
Show more Clinical

Similar Articles

Keywords

  • 18F-PSMA-1007
  • PET/CT
  • hybrid imaging
  • prostate cancer
  • biochemical recurrence
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire